37561 |
Biology |
Treatment and Outcomes of Metastatic Non-Small-Cell Lung Cancer Harbor... |
BIOLOGY-BASEL 2020 10.3390/biology9100326 |
선종무 |
2020 |
37560 |
Multidisciplinary Sciences |
Regulatory -(FoxP3(+)) T cells and TGF-beta predict the response to an... |
SCI REP-UK 2020 10.1038/s41598-020-76130-1 |
선종무 |
2020 |
37559 |
Oncology; Respiratory System |
Ten-year patient journey of stage III non-small cell lung cancer patie... |
LUNG CANCER 2020 10.1016/j.lungcan.2020.05.033 |
선종무 |
2020 |
37558 |
Oncology; Respiratory System |
Real world data of durvalumab consolidation after chemoradiotherapy in... |
LUNG CANCER 2020 10.1016/j.lungcan.2020.05.035 |
선종무 |
2020 |
37557 |
Pharmacology & Pharmacy |
Phase I clinical trial of KML001 monotherapy in patients with advanced... |
EXPERT OPIN INV DRUG 2020 10.1080/13543784.2020.1804855 |
선종무 |
2020 |
37556 |
Oncology; Respiratory System |
Osimertinib Improves Overall Survival in Patients With EGFR-Mutated NS... |
J THORAC ONCOL 2020 10.1016/j.jtho.2020.06.018 |
선종무 |
2020 |
37555 |
Oncology |
Mouse-human co-clinical trials demonstrate superior anti-tumour effect... |
BRIT J CANCER 2020 10.1038/s41416-020-01074-2 |
선종무 |
2020 |
37554 |
Immunology |
Immunological Characteristics of Hyperprogressive Disease in Patients ... |
IMMUNE NETW 2020 10.4110/in.2020.20.e48 |
선종무 |
2020 |
37553 |
Oncology |
HLA-corrected tumor mutation burden and homologous recombination de fi... |
ANN ONCOL 2020 10.1016/j.annonc.2020.04.004 |
선종무 |
2020 |
37552 |
Pharmacology & Pharmacy |
Evaluating entrectinib as a treatment option for non-small cell lung c... |
EXPERT OPIN PHARMACO 2020 10.1080/14656566.2020.1798932 |
선종무 |
2020 |